Table 3.
Effect of TKA design: posterior stabilized vs posterior retaining.
| TKA design | P-value | |||
|---|---|---|---|---|
| Posterior Stabilized | Posterior Retaining | |||
| Control | Transfusion; no/yes n (%) | 11 (39.3) / 17 (60.7) | 3 (23,1) / 10 (76.9) | 0.481 |
| Days of hospitalization; mean±SD | 8.50±3.39 | 6.23±1.78 | 0.030 | |
| Hgb max diff; mean±SD | -3.42±1.61 | -3.11±0.97 | 0.456 | |
| ivTXA | Transfusion; no/yes n (%) | 13 (86.7) / 2 (13.3) | 25 (96.2) / 1 (3.8) | 0.543 |
| Days of hospitalization; mean±SD | 5.50±1.34 | 4.46±1.33 | 0.024 | |
| Hgb max diff; mean±SD | -2.85±1.23 | -2.71±1.00 | 0.695 | |
| locTXA | Transfusion; no/yes n (%) | 12 (80.0) / 3 (20.0) | 26 (96.3) / 1 (3.7) | 0.122 |
| Days of hospitalization; mean±SD | 5.40±0.74 | 4.48±1.05 | 0.005 | |
| Hgb max diff; mean±SD | -2.41±1.03 | -2.31±0.85 | 0.758 | |
TKA, total knee arthroplasty; THA, total hip arthroplasty.